The United States Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

Distribution issues and volatile material prices have caused ophthalmic instrument sales to waver over the past five years. As the population of the United States ages, the number of consumers suffering from eye conditions will rise. Older individuals are more susceptible to developing macular degeneration, cataracts, glaucoma and diabetic retinal disease. Thus, demand for ophthalmology procedures rises as the domestic population ages, boosting ophthalmic instrument sales. However, trade disruptions and inflation have caused material prices to rise, driving up the cost of ophthalmic instruments. As the cost of ophthalmic care rises and consumers face tighter budgets, people are more likely to forgo non-essential ophthalmic procedures like LASIK. As a result, revenue has declined at a CAGR of 0.9% to $3.7 billion over the five years to 2025. The globalized nature of the industry results in prominent competition from foreign producers, which was enhanced by the appreciation of the US dollar, making domestic instruments comparatively more expensive. Although imports satisfy a large portion of domestic demand, the popularity and perceived quality of US-produced instruments will continue to drive growth. Meanwhile, the US has begun taking a more aggressive approach to international trade by imposing sweeping tariffs on foreign-made goods. While these policies have created volatility, they have made imported ophthalmic instruments more expensive, at least in the short term. Domestic manufacturers will benefit from less competition and greater domestic demand. However, other countries have imposed reciprocal tariffs that will impact foreign demand for US ophthalmic instruments. Technological advancements in surgical techniques, such as minimally invasive direct energy-based laser procedures, have made eye surgery quicker and less painful with shorter recovery times. Thus, modern surgical techniques and more affordable eyecare have also prompted increased visits to ophthalmologists and optometrists, boosting demand for ophthalmic equipment and making manufacturers more profitable. The rising average age of the population is likely to lead to rising demand for ophthalmology procedures, supporting manufacturers' performance. These trends are expected to cause revenue to grow at an estimated CAGR of 2.1% to $4.1 billion over the years to 2030.

United States Eye Care Market is expected to witness rapid growth through 2027 owing to the increasing number of people suffering from myopia, hyperopia or other optical issues. US Eye Care Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast 2027 By Product Type, By Coating, By Lens Material, By End User, By Region, Forecast & Opportunities, 2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

The ophthalmic diagnostic equipment market is expected to grow from USD 3.56 billion in 2025 to USD 5.02 billion by 2035. The market is poised to expand at a 3.5% CAGR during the forecast period.

Metric	Value
Industry Size (2025E)	USD 3.56 billion
Industry Value (2035F)	USD 5.02 billion
CAGR (2025 to 2035)	3.5%

Ophthalmic Diagnostic Equipment Market Analyzed by Top Investment Segments

Product	CAGR (2025-2035)
Optical Coherence Tomography (OCT)	5.1%

End Use	CAGR (2025-2035)
Ambulatory Surgical Centres	4.8%

Analyzing Top Countries Producing and Distributing Ophthalmic Diagnostic Equipment

Countries	CAGR (2025-2035)
United States	5.4%
United Kingdom	4.5%
France	7.2%
Germany	6.1%
Japan	2%

The US ophthalmic devices market, a significant segment of the global industry, is experiencing robust growth, fueled by several key factors. An aging population with increased prevalence of age-related eye diseases like cataracts, glaucoma, and macular degeneration is driving demand for diagnostic, surgical, and vision correction devices. Technological advancements, particularly in minimally invasive surgical techniques like laser refractive surgery (LASIK) and advanced imaging technologies like optical coherence tomography (OCT), are enhancing treatment options and improving patient outcomes. This, in turn, is stimulating market expansion. Furthermore, increasing healthcare expenditure and rising disposable incomes are contributing to greater access to advanced ophthalmic care, particularly in the private sector. The market is segmented by device type, with surgical devices (including glaucoma drainage devices, intraocular lenses, and lasers) and diagnostic and monitoring devices (like OCT scanners and ophthalmoscopes) commanding the largest shares. The competitive landscape includes both established multinational corporations and specialized smaller companies, fostering innovation and competition. While challenges such as stringent regulatory approvals and high device costs persist, the overall outlook for the US ophthalmic devices market remains positive, projecting sustained growth throughout the forecast period. Considering the provided CAGR of 6.90% and a global market size (assuming the provided "XX" is for the global market) which we can reasonably estimate in the tens of billions, the US market, which is a substantial portion of the global market, likely represents a significant share. Let’s hypothetically assume the US represents 40% of the global market. If the global market was, for example, $30 billion, the US market would be approximately $12 billion in 2025. With a CAGR of 6.90%, we can project future growth. While precise figures require more specific data, this illustrative calculation demonstrates the market's considerable size and substantial growth potential. This substantial market size, coupled with the aforementioned driving factors (aging population, technological advancements, increased healthcare spending), positions the US ophthalmic devices sector for continuous expansion over the coming years. The market's segmentation into surgical, diagnostic, and vision correction devices reflects the diversity of treatment options available and the breadth of opportunities for market players. Recent developments include: November 2022: Sight Sciences reported a publication of clinical data demonstrating the standalone effectiveness of the OMNI Surgical System in pseudophakic glaucoma patients with uncontrolled pressure following a previous combination cataract stent procedure., August 2022: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent infinite Trabecular Micro-Bypass System indicated for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma uncontrolled by prior medical and surgical therapy.. Key drivers for this market are: Demographic Shift and Increasing Prevalence of Eye Diseases, Rising Geriatric Population; Technological Advancements in Ophthalmic Devices. Potential restraints include: Demographic Shift and Increasing Prevalence of Eye Diseases, Rising Geriatric Population; Technological Advancements in Ophthalmic Devices. Notable trends are: Contact Lens are Expected to Register a Significant Growth in the United States Ophthalmic Devices Market Over the Forecast Period.

United States Ophthalmic Equipment Market Size, Share, Growth, Trend & US Ophthalmic Equipment Market Analysis 2027, By Product, By Application, By End User, By Region, Competition Forecast & Opportunities,

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

This statistic shows the value of the prescribed ophthalmology market in the United States from 2009 to 2014. It is the branch of medicine that deals with the diagnosis and treatment of diseases and disorders of the eye. In 2014, some *** billion U.S. dollars were spent in this area, making this therapeutic area one of the top therapeutic classes in the United States.

The global ophthalmic surgical market is expected to grow at a CAGR of 5.7% from 2024 to 2034. The market value is projected to increase from US$ 13,937.8 million in 2024 to US$ 24,194.2 million by 2034.

Attributes	Key Insights
Base Value, 2023	US$ 13,159.7 million
Estimated Global Ophthalmic Surgical Market Size (2024E)	US$ 13,937.8 million
Projected Ophthalmic Surgical Market Value (2034F)	US$ 24,194.2 million
Value-based CAGR (2024 to 2034)	5.7%

Country-wise Insights

Country	Value CAGR
United States	8.3%
Japan	8.1%
China	7.1%
Germany	7.7%
United Kingdom	7.3%

Category-wise Insights

Segment	Value CAGR
Consumable (Product Type)	5.3%
Ophthalmic Clinics (Distribution Channel)	5.3%

The Brazilian ophthalmic devices market is anticipated to reach a valuation of million by 2033, exhibiting a CAGR of 5.8% during the forecast period of 2023-2030. The market's growth is primarily attributed to increasing prevalence of eye diseases, rising disposable income, and technological advancements in ophthalmic devices. Brazil is home to a substantial population with age-related eye conditions like cataracts and glaucoma, which has led to a surge in demand for surgical and diagnostic ophthalmic devices. Additionally, the country's expanding healthcare infrastructure and favorable government policies supporting the healthcare sector are fostering market growth. Key drivers of the Brazilian ophthalmic devices market include the increasing incidence of eye diseases, rising healthcare expenditure, and advancements in ophthalmic technologies. The market is segmented into surgical devices, diagnostic and monitoring devices, and vision correction devices. Surgical devices hold the largest market share due to the high prevalence of eye surgeries, such as cataract and refractive surgeries. Diagnostic and monitoring devices are also witnessing significant growth due to the rising demand for early detection and management of eye diseases. Technological advancements, such as the development of intraocular lenses and laser systems, are further driving market expansion. Recent developments include: In July 2021, Johnson & Johnson Vision announced the global availability of the VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort., In July 2021, CooperVision has teamed up with Plastic Bank, which operates in Haiti, Brazil, Indonesia, the Philippines, and Egypt to transform the clariti 1-day lens family into the first net plastic-neutral contact lens in the United States.. Key drivers for this market are: Increasing Prevalence of Eye Disease, Increasing Geriatric Population. Potential restraints include: Shortage of Skilled Professionals. Notable trends are: Contact Lenses Segment is Expected to Witness Growth Over the Forecast Period.

The size of the US Ophthalmic Devices Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 6.90% during the forecast period. The U.S. Ophthalmic Devices Industry develops, manufactures, and markets diagnostic, monitoring, and therapeutic medical equipment designed for diagnosis and treatment of disorders and diseases related to the eyes. The scope of ophthalmic devices includes intraocular lenses, contact lenses, surgical instruments, diagnostic equipment, and laser systems among others. Indeed, such devices are important in restoring vision and improving the sight of millions among the country's population. IOLs are implanted during cataract surgery to replace the cloudy lens in the eye. Contact lenses are used for refractive problems like myopia, hyperopia, and astigmatism. There are surgical devices used for different types of eye treatments like cataract surgery, glaucoma surgery, and retina detachment treatment. Diagnostic instruments containing an ophthalmoscope and tonometer are involved during the initial stages of diagnosis and observation of many ocular diseases. These laser systems are applied to hundreds of procedures like vision correction, treatment of glaucoma condition, retinal surgery, etc. What drives the U.S. ophthalmic devices industry are factors relating to an aging population with increasing rates of eye diseases, technology advancements, and greater interest in prevention eye care. Moreover, it receives a boost from an effective regulatory framework, such as the FDA, whereby ophthalmic devices are safe and effective. Recent developments include: November 2022: Sight Sciences reported a publication of clinical data demonstrating the standalone effectiveness of the OMNI Surgical System in pseudophakic glaucoma patients with uncontrolled pressure following a previous combination cataract stent procedure., August 2022: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent infinite Trabecular Micro-Bypass System indicated for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma uncontrolled by prior medical and surgical therapy.. Key drivers for this market are: Demographic Shift and Increasing Prevalence of Eye Diseases, Rising Geriatric Population; Technological Advancements in Ophthalmic Devices. Potential restraints include: Risk Associated with Ophthalmic Procedures. Notable trends are: Contact Lens are Expected to Register a Significant Growth in the United States Ophthalmic Devices Market Over the Forecast Period.

The United States Ophthalmic Lasers Market was valued at USD 446.31 Million in 2024 and is expected to reach USD 608.61 Million by 2030 with a CAGR of 5.28%.

Pages	84
Market Size	2024: USD 446.31 Million
Forecast Market Size	2030: USD 608.61 Million
CAGR	2025-2030: 5.28%
Fastest Growing Segment	Cataract Removal
Largest Market	Mid-West
Key Players	1. Alcon Laboratories, Inc. 2. Carl Zeiss Meditec AG 3. Ellex Medical Lasers Limited 4. Abbott Medical Optics, Inc. 5. Bausch & Lomb Incorporated 6. Topcon Corporation 7. IRIDEX Corporation 8. Lumenis Be Ltd. 9. Ziemer Ophthalmic Systems AG 10. NIDEK Co., Ltd.

The ophthalmic injectable market size is projected to be worth US$ 18.8 Billion in 2023. The market is likely to surpass US$ 30.2 Billion by 2033 at a CAGR of 4.9% during the forecast period. The increasing frequency of aberrant blood vessel growth or blood vessel hemorrhage in an effort to support market expansion. Numerous retinal disorders, such as wet age-related macular degeneration (AMD) and diabetic retinopathy, are linked to abnormal blood vessels. Repeated injections are frequently necessary, particularly for long-lasting diseases like AMD and diabetic retinopathy. So promoting market expansion.

Attributes	Details
Ophthalmic Injectable Market Size (2023)	US$ 18.8 Billion
Ophthalmic Injectable Market Projected Size (2033)	US$ 30.2 Billion
Value CAGR (2023 to 2033)	4.9%

Country-Wise Insights

Country	The United States
Market Size (US$ billion) by End of Forecast Period (2033)	US$ 11.9 billion
CAGR % 2023 to End of Forecast (2033)	4.7%

Country	The United Kingdom
Market Size (US$ billion) by End of Forecast Period (2033)	US$ 800.0 million
CAGR % 2023 to End of Forecast (2033)	4.4%

Country	China
Market Size (US$ billion) by End of Forecast Period (2033)	US$ 1.7 billion
CAGR % 2023 to End of Forecast (2033)	5.4%

Country	Japan
Market Size (US$ billion) by End of Forecast Period (2033)	US$ 755.0 million
CAGR % 2023 to End of Forecast (2033)	4.2%

Country	South Korea
Market Size (US$ billion) by End of Forecast Period (2033)	US$ 395.0 million
CAGR % 2023 to End of Forecast (2033)	4.1%

Learn about the projected growth of the ophthalmic instruments and appliances market in the United States, with an expected increase in both volume and value over the next decade.

The North America Ophthalmic Drugs and Devices Market Ris Segmented by Product (Devices {Surgical Devices, Diagnostic Devices, and More} and Drugs {Glaucoma Drugs, Retinal Disorder Drugs, and More), Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and More), and Geography (United States, Canada, Mexico). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Statistics illustrates market overview of ophthalmic goods in the United States from 2013 to 2024.

This industry wholesales ophthalmic equipment. Ophthalmic equipment includes medical instruments that are related to eye care or are used in eye-related medical procedures.

Discover the projected growth of the ophthalmic instruments and appliances market in the United States over the next decade, with an expected increase in market volume and value by 2035.

The ophthalmic drug packaging market had an estimated market share worth US$ 276 million in 2023, and it is predicted to reach a global market valuation of US$ 527.8 million by 2034, growing at a CAGR of 6.1% from 2024 to 2034.

Report Attribute	Details
Estimated Market Value in 2023	US$ 276 million
Expected Market Value in 2024	US$ 292.2 million
Projected Forecast Value in 2034	US$ 527.8 million
Anticipated Growth Rate from 2024 to 2034	6.1%

Ophthalmic Drug Packaging Market Historical Analysis 2019 to 2023 vs. Forecast Outlook 2024 to 2034

Historical CAGR 2019 to 2023	5.6%
Forecast CAGR 2024 to 2034	6.1%

Category wise Insights

Dose Type	Multi Dose
Market Share in 2024	81.7%

End Use	Prescription
Market Share in 2024	64.2%

Region wise Analysis

Countries	Forecast CAGR from 2024 to 2034
The United States	11.9%
The United Kingdom	12.9%
China	12.7%
Japan	13%
South Korea	14.1%

Comprehensive dataset of 5,510 Ophthalmology clinics in United States as of August, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The global ophthalmic eye drop market is expected to grow from US$ 17,271.8 million in 2024 to US$ 25,876.4 million by 2034. By 2034, the market is projected to surge at 4.7% CAGR. The ophthalmic eye drop market was valued at US$ 16,390.6 million in 2023 and is anticipated to exhibit a y-o-y growth of 5.4% in 2024.

Attributes	Key Insights
Base Value (2023)	US$ 16,390.6 million
Estimated Global Ophthalmic Eye Drop Market Size (2024E)	US$ 17,271.8 million
Projected Ophthalmic Eye Drop Market Value (2034F)	US$ 25,876.4 million
Value-based CAGR (2024 to 2034)	4.7%

Country-wise Insights

Countries	Value CAGR (2024 to 2034)
United States	5.0%
China	6.6%
Germany	1.8%
United Kingdom	5.4%
Japan	6.2%

Category-wise Insights

Segment	Value CAGR (2024 to 2034)
Steroid Drops (Products)	4.8%
Multiple-Dose Container (Container Type)	4.3%
With Preservative (Drug Formulation)	4.1%
Dry Eye (Indication)	2.2%